IT1213390B - Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo. - Google Patents

Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.

Info

Publication number
IT1213390B
IT1213390B IT8622510A IT2251086A IT1213390B IT 1213390 B IT1213390 B IT 1213390B IT 8622510 A IT8622510 A IT 8622510A IT 2251086 A IT2251086 A IT 2251086A IT 1213390 B IT1213390 B IT 1213390B
Authority
IT
Italy
Prior art keywords
changes
pharmaceutical compositions
oral use
type containing
time controlled
Prior art date
Application number
IT8622510A
Other languages
English (en)
Other versions
IT8622510A0 (it
Inventor
E Giuliano Frigerio
Virginio Castagnola
Original Assignee
Gipharmex Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gipharmex Spa filed Critical Gipharmex Spa
Priority to IT8622510A priority Critical patent/IT1213390B/it
Publication of IT8622510A0 publication Critical patent/IT8622510A0/it
Priority to EP87202214A priority patent/EP0273469A1/en
Priority to JP62297867A priority patent/JPS63145232A/ja
Application granted granted Critical
Publication of IT1213390B publication Critical patent/IT1213390B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IT8622510A 1986-11-28 1986-11-28 Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo. IT1213390B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT8622510A IT1213390B (it) 1986-11-28 1986-11-28 Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.
EP87202214A EP0273469A1 (en) 1986-11-28 1987-11-13 Oral pharmaceutical compositions with sustained release
JP62297867A JPS63145232A (ja) 1986-11-28 1987-11-27 コレステロール代謝変化治療用薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8622510A IT1213390B (it) 1986-11-28 1986-11-28 Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.

Publications (2)

Publication Number Publication Date
IT8622510A0 IT8622510A0 (it) 1986-11-28
IT1213390B true IT1213390B (it) 1989-12-20

Family

ID=11197236

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8622510A IT1213390B (it) 1986-11-28 1986-11-28 Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.

Country Status (3)

Country Link
EP (1) EP0273469A1 (it)
JP (1) JPS63145232A (it)
IT (1) IT1213390B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096904A (en) * 1989-09-01 1992-03-17 Glaxo Inc. Pyridazinones having cardiotonic and beta blocking activities
IT1257793B (it) * 1992-05-18 1996-02-13 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
ATE195871T1 (de) 1997-09-23 2000-09-15 Akzo Nobel Nv Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung
JP4583675B2 (ja) 2001-08-30 2010-11-17 ナイルス株式会社 スイッチ
CA2679608A1 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis
US9848874B2 (en) 2014-02-14 2017-12-26 Covidien Lp Small diameter endoscopic stapler

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859437A (en) * 1972-06-02 1975-01-07 Intellectual Property Dev Corp Reducing cholesterol levels
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1142639B (it) * 1981-12-29 1986-10-08 Proter Spa Composizioni terapeutiche ad attivita' coleretica contenenti come principio attivo derivati dall'acido colanico

Also Published As

Publication number Publication date
EP0273469A1 (en) 1988-07-06
JPS63145232A (ja) 1988-06-17
IT8622510A0 (it) 1986-11-28

Similar Documents

Publication Publication Date Title
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
FR2502951B1 (fr) Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
DK35287D0 (da) Stabilt, oralt, enkelt enhedsdosisprodukt
DE3784594D1 (de) Mikrokapseln enthaltende pharmazeutische zusammensetzungen.
NZ183222A (en) Azetidine pyrrolidine-orpiperidine-2-carboxylic acid derivatives and pharmaceutical compositions
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
IT8720621A0 (it) Formulazioni di steroide in soluzione acquosa per somministrazione nasale.
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI872313A0 (fi) Farmaceutiska kompositioner.
IT1208002B (it) Erogatore di tovagliolini a selezione facilitata del numero di tovagliolini da erogare.
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
IT1213390B (it) Composizioni farmaceutiche ad uso orale del tipo a cessione controllata nel tempo contenenti composti a struttura steroidea attivi nelle alterazioni del metabolismo del colesterolo.
ATE5188T1 (de) Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
IT1231410B (it) Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
GB2194733B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.